These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 29428643)

  • 1. Drug testing and characterization using human-on-chip (HoC) systems: some thoughts on the application of in vitro-in vivo correlation.
    Somayaji MR; Das D; Przekwas AJ
    Drug Discov Today; 2018 Sep; 23(9):1571-1573. PubMed ID: 29428643
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent Advances in Body-on-a-Chip Systems.
    Sung JH; Wang YI; Narasimhan Sriram N; Jackson M; Long C; Hickman JJ; Shuler ML
    Anal Chem; 2019 Jan; 91(1):330-351. PubMed ID: 30472828
    [No Abstract]   [Full Text] [Related]  

  • 3. Microfluidic cell chips for high-throughput drug screening.
    Chi CW; Ahmed AR; Dereli-Korkut Z; Wang S
    Bioanalysis; 2016 May; 8(9):921-37. PubMed ID: 27071838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microphysiological systems for ADME-related applications: current status and recommendations for system development and characterization.
    Fowler S; Chen WLK; Duignan DB; Gupta A; Hariparsad N; Kenny JR; Lai WG; Liras J; Phillips JA; Gan J
    Lab Chip; 2020 Feb; 20(3):446-467. PubMed ID: 31932816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biofabrication of a three-dimensional liver micro-organ as an in vitro drug metabolism model.
    Chang R; Emami K; Wu H; Sun W
    Biofabrication; 2010 Dec; 2(4):045004. PubMed ID: 21079286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microfluidic cell culture systems for drug research.
    Wu MH; Huang SB; Lee GB
    Lab Chip; 2010 Apr; 10(8):939-56. PubMed ID: 20358102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organs on Chips 2013.
    Beebe DJ; Ingber DE; den Toonder J
    Lab Chip; 2013 Sep; 13(18):3447-8. PubMed ID: 23918086
    [No Abstract]   [Full Text] [Related]  

  • 8. Microprinting of liver micro-organ for drug metabolism study.
    Chang RC; Emami K; Jeevarajan A; Wu H; Sun W
    Methods Mol Biol; 2011; 671():219-38. PubMed ID: 20967633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pharmaceutical industry perspective on microphysiological kidney systems for evaluation of safety for new therapies.
    Phillips JA; Grandhi TSP; Davis M; Gautier JC; Hariparsad N; Keller D; Sura R; Van Vleet TR
    Lab Chip; 2020 Feb; 20(3):468-476. PubMed ID: 31989145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cocktail of metabolic probes demonstrates the relevance of primary human hepatocyte cultures in a microfluidic biochip for pharmaceutical drug screening.
    Prot JM; Videau O; Brochot C; Legallais C; Bénech H; Leclerc E
    Int J Pharm; 2011 Apr; 408(1-2):67-75. PubMed ID: 21295126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smart Cell Culture Monitoring and Drug Test Platform Using CMOS Capacitive Sensor Array.
    Nabovati G; Ghafar-Zadeh E; Letourneau A; Sawan M
    IEEE Trans Biomed Eng; 2019 Apr; 66(4):1094-1104. PubMed ID: 30139044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microfluidic whole blood testing of platelet response to pharmacological agents.
    Li R; Grosser T; Diamond SL
    Platelets; 2017 Jul; 28(5):457-462. PubMed ID: 28102731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Bioprinted Liver-on-a-Chip for Drug Screening Applications.
    Knowlton S; Tasoglu S
    Trends Biotechnol; 2016 Sep; 34(9):681-682. PubMed ID: 27291461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A microfluidic platform for pharmaceutical salt screening.
    Thorson MR; Goyal S; Schudel BR; Zukoski CF; Zhang GG; Gong Y; Kenis PJ
    Lab Chip; 2011 Nov; 11(22):3829-37. PubMed ID: 21956673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detecting and Trapping of a Single C. elegans Worm in a Microfluidic Chip for Automated Microplate Dispensing.
    Desta IT; Al-Sharif A; AlGharibeh N; Mustafa N; Orozaliev A; Giakoumidis N; Gunsalus KC; Song YA
    SLAS Technol; 2017 Aug; 22(4):431-436. PubMed ID: 27630097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Label-free integrative pharmacology on-target of drugs at the β(2)-adrenergic receptor.
    Ferrie AM; Sun H; Fang Y
    Sci Rep; 2011; 1():33. PubMed ID: 22355552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human-on-a-chip design strategies and principles for physiologically based pharmacokinetics/pharmacodynamics modeling.
    Abaci HE; Shuler ML
    Integr Biol (Camb); 2015 Apr; 7(4):383-91. PubMed ID: 25739725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Laminated Microfluidic Device for Comprehensive Preclinical Testing in the Drug ADME Process.
    An F; Qu Y; Luo Y; Fang N; Liu Y; Gao Z; Zhao W; Lin B
    Sci Rep; 2016 Apr; 6():25022. PubMed ID: 27122192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Centrifugal microfluidic platform for single-cell level cardiomyocyte-based drug profiling and screening.
    Espulgar W; Aoki W; Ikeuchi T; Mita D; Saito M; Lee JK; Tamiya E
    Lab Chip; 2015 Sep; 15(17):3572-80. PubMed ID: 26215661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artificial microorgans: a microfluidic tool for in vitro assessment of toxicity.
    Schütte J; Stelzle M
    Bioanalysis; 2011 Nov; 3(21):2373-5. PubMed ID: 22074276
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.